Topiramate

CAS 97240-79-4 26 API suppliersSmall Molecule

Overview

Topiramate is a medication used primarily to treat epilepsy and prevent migraines. It is known for its broad-spectrum anticonvulsant properties and is generally well-tolerated in diverse patient populations.

API suppliers (26)

Suppliers of Topiramate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India14China1USA1Taiwan1Switzerland1Hungary1

Country recorded for 19 of 26 suppliers.

15 of 26 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 26 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (132 approved US products), the latest listed US patent on Topiramate expires 21 Aug 2040 and exclusivity 1 Feb 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

AntiepilepticMigraine Prevention
Verified Supplier Partner

Do you supply Topiramate? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.